P1747: A REAL-WORLD ANALYSIS OF HEALTHCARE RESOURCE UTILIZATION AMONG PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA WHO RECEIVED TREATMENT WITH RAVULIZUMAB

P1747: A REAL-WORLD ANALYSIS OF HEALTHCARE RESOURCE UTILIZATION AMONG PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA WHO RECEIVED TREATMENT WITH RAVULIZUMAB

Bibliographic Details
Main Authors:	J. Fishman, S. Kuranz, M. Yeh, K. Brzozowski, H. Chen
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000849844.54528.5f

Similar Items

Changes in Hematologic Lab Measures Observed in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with C5 Inhibitors, Ravulizumab and Eculizumab: Real-World Evidence from a US Based EMR Network
by: Jesse Fishman, et al.
Published: (2023-04-01)

Switching From High-Dose Eculizumab to Ravulizumab in Paroxysmal Nocturnal Hemoglobinuria: A Case Report
by: Wolfgang Füreder, et al.
Published: (2020-08-01)

P834: REAL-WORLD EVIDENCE OF SAFETY AND EFFECTIVENESS OF ECULIZUMAB AND SWITCH TO RAVULIZUMAB IN A SWISS PATIENT POPULATION WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
by: A. Rovó, et al.
Published: (2022-06-01)

Paroxysmal Nocturnal Hemoglobinuria
by: Buddhi P Paudyal, et al.
Published: (2005-01-01)

P813: EFFICACY, TREATMENT ADMINISTRATION SATISFACTION AND SAFETY OF SUBCUTANEOUS RAVULIZUMAB THROUGH 1 YEAR IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA WHO RECEIVED PRIOR INTRAVENOUS ECULIZUMAB
by: M. N. Yenerel, et al.
Published: (2022-06-01)

Treatment of paroxysmal nocturnal hemoglobinuria
by: I. A. Lisukov, et al.
Published: (2014-07-01)

Paroxysmal nocturnal hemoglobinuria and eculizumab
by: Lucio Luzzatto, et al.
Published: (2010-04-01)

Treatment of paroxysmal nocturnal hemoglobinuria
by: I. A. Lisukov, et al.
Published: (2014-07-01)

P840: A MATCHING-ADJUSTED INDIRECT COMPARISON OF THE EFFICACY OF PEGCETACOPLAN USING PRINCE TRIAL DATA VERSUS RAVULIZUMAB AND ECULIZUMAB IN COMPLEMENT-NAÏVE PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
by: R. Wong, et al.
Published: (2022-06-01)

Characterization of breakthrough hemolysis events observed in the phase 3 randomized studies of ravulizumab versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria
by: Robert A. Brodsky, et al.
Published: (2020-01-01)

Non-capsulated Neisseria meningitidis sepsis in a paroxysmal nocturnal hemoglobinuria patient treated with ravulizumab: case report and review of the literature
by: Nicole Galli, et al.
Published: (2023-10-01)

Paroxysmal nocturnal hemoglobinuria: the path to diagnosis
by: E. F. Makhnyr, et al.
Published: (2019-04-01)

Necrotizing Fasciitis in Paroxysmal Nocturnal Hemoglobinuria
by: Pusem Patir, et al.
Published: (2015-01-01)

Current Insights into Paroxysmal Nocturnal Hemoglobinuria
by: Wanchai Wanachiwanawin
Published: (2020-07-01)

Paroxysmal Nocturnal Hemoglobinuria: Biology and Treatment
by: Carlos Bravo-Perez, et al.
Published: (2023-09-01)

P812: LONG-TERM COMPLEMENT INHIBITION AND SURVIVAL OUTCOMES IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: AN INTERIM ANALYSIS OF THE RAVULIZUMAB CLINICAL TRIALS
by: A. Kulasekararaj, et al.
Published: (2022-06-01)

Real-World Study of US Adults with Paroxysmal Nocturnal Hemoglobinuria Treated with Pegcetacoplan
by: Brian Mulherin, et al.
Published: (2024-10-01)

Stem cell transplantation for paroxysmal nocturnal hemoglobinuria
by: Robert A. Brodsky
Published: (2010-06-01)

Investigational workout for the diagnosis of paroxysmal nocturnal hemoglobinuria
by: Omar Abdulaziz Alnujeidi, et al.
Published: (2023-01-01)

Paroxysmal nocturnal hemoglobinuria in the differential diagnosis of thrombocytopenia
by: Fusun Gediz, et al.
Published: (2017-03-01)

Evaluation of hemostasis and endothelial function in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab
by: Dominique Helley, et al.
Published: (2010-04-01)

P757: INCIDENCE RATES OF HEALTHCARE RESOURCE UTILIZATION AND HEMOGLOBIN LEVELS DURING OPERA: A REAL-WORLD STUDY OF PEGCETACOPLAN TREATMENT IN US ADULTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
by: Jesse Fishman, et al.
Published: (2023-08-01)

Terminal complement inhibition and control of hemolysis in patients with paroxysmal nocturnal hemoglobinuria who switched from high-dose eculizumab to ravulizumab: a phase IV, single-arm clinical trial
by: Morag Griffin, et al.
Published: (2024-11-01)

Paroxysmal Nocturnal Hemoglobinuria: Diagnostic Challenges in Pediatric Patient
by: Dharshana Krishnaprasadh, et al.
Published: (2019-01-01)

Diagnostic and Treatment Challenges of Paroxysmal Nocturnal Hemoglobinuria in Uganda
by: Boniface Amanee Elias Lumori, et al.
Published: (2019-01-01)

PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) DENGAN HYPERCOAGULABLE STATE
by: Fitrach Desfiyanda, et al.
Published: (2018-07-01)

A case of paroxysmal nocturnal hemoglobinuria with renal hemosiderosis
by: Parimal B Patel, et al.
Published: (2019-01-01)

Autosplenectomy in a Patient with Paroxysmal Nocturnal Hemoglobinuria (PNH)
by: Ethan Burns, et al.
Published: (2019-01-01)

Allogeneic stem cell transplantation in paroxysmal nocturnal hemoglobinuria
by: Régis Peffault de Latour, et al.
Published: (2012-11-01)

Understanding pharmacological complement inhibition in paroxysmal nocturnal hemoglobinuria
by: Antonio M. Risitano, et al.
Published: (2023-09-01)

Phase II trials of zilucoplan in paroxysmal nocturnal hemoglobinuria
by: Austin G. Kulasekararaj, et al.
Published: (2023-08-01)

Significant hemolysis is not required for thrombosis in paroxysmal nocturnal hemoglobinuria
by: Morag Griffin, et al.
Published: (2019-03-01)

P771: PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA AND CLINICALLY SIGNIFICANT EXTRAVASCULAR HEMOLYSIS ON RAVULIZUMAB/ECULIZUMAB SHOWED HEMOGLOBIN RESPONSE SUPERIORITY WITH ADD-ON DANICOPAN VS PLACEBO
by: Jong Wook Lee, et al.
Published: (2023-08-01)

The cost–effectiveness of pegcetacoplan in complement treatment-naive adults with paroxysmal nocturnal hemoglobinuria in the USA
by: Jesse Fishman, et al.
Published: (2023-09-01)

Treatment Patterns and Healthcare Resource Utilization of Patients With Paroxysmal Nocturnal Hemoglobinuria: A Retrospective Claims Data Analysis
by: Denise Clayton PhD, et al.
Published: (2024-01-01)

Patient-reported outcomes and daily activity assessed with a digital wearable device in patients with paroxysmal nocturnal hemoglobinuria treated with ravulizumab: REVEAL, a prospective, observational study
by: Elizabeth A. Griffiths, et al.
Published: (2024-08-01)

The role of high-dose methylprednisolone therapy in paroxysmal nocturnal hemoglobinuria
by: E Erduran, et al.
Published: (1995-07-01)

National clinical guidelines for the diagnosis and treatment of paroxysmal nocturnal hemoglobinuria
by: A. D. Kulagin, et al.
Published: (2014-09-01)

Response of Paroxysmal Nocturnal Hemoglobinuria Clone with Aplastic Anemia to Rituximab
by: Radha Raghupathy, et al.
Published: (2012-01-01)

Paroxysmal Nocturnal Hemoglobinuria in Pregnancy: A Dilemma in Treatment and Thromboprophylaxis
by: Arpan Patel, et al.
Published: (2017-01-01)